J05AF Nucleoside and nucleotide reverse transcriptase inhibitors
ATC group of level 4 – chemical subgroup · in plain English: medicines against viruses, e.g. HIV or hepatitis
This site has the patient leaflet or the SPC of 82 medicines in this group and its subgroups.
- 64 prescription only (POM)
- 11 no longer supplied or not available
Place in the ATC classification
- J Antiinfectives for systemic use 1,393 medicines
- J05 Antivirals for systemic use 392 medicines
- J05A Direct acting antivirals 392 medicines
-
J05AF Nucleoside and nucleotide reverse transcriptase inhibitors 82 medicines
- J05AF01 zidovudine 6 medicines
- J05AF04 stavudine 1 medicine
- J05AF05 lamivudine 16 medicines
- J05AF06 abacavir 6 medicines
- J05AF07 tenofovir disoproxil 21 medicines
- J05AF08 adefovir dipivoxil 2 medicines
- J05AF09 emtricitabine 2 medicines
- J05AF10 entecavir 26 medicines
- J05AF11 telbivudine 1 medicine
-
J05AF Nucleoside and nucleotide reverse transcriptase inhibitors 82 medicines
- J05A Direct acting antivirals 392 medicines
- J05 Antivirals for systemic use 392 medicines
4 more subgroups have no medicine with a leaflet on this site.
Active substances in the group
- Abacavir 6 medicines
- Adefovir 2 medicines
- Emtricitabine 2 medicines
- Entecavir 26 medicines
- Lamivudine 16 medicines
- Stavudine 1 medicine
- Telbivudine 1 medicine
- Tenofovir alafenamide 1 medicine
- Tenofovir disoproxil 21 medicines
- Zidovudine 6 medicines
Medicines in the group and its subgroups
Other groups of the same level
- J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors 40 medicines
- J05AD Phosphonic acid derivatives, direct acting antivirals 2 medicines
- J05AE Protease inhibitors, direct acting antivirals 75 medicines
- J05AG Non-nucleoside reverse transcriptase inhibitors 32 medicines
- J05AH Neuraminidase inhibitors, direct acting antivirals 14 medicines
- J05AJ Integrase Inhibitors, antiinfectives for systematic use 15 medicines
- J05AP Antivirals for treatment of HCV infections 25 medicines
- J05AR Antivirals for treatment of HIV infections, combinations 80 medicines
- J05AX Other antivirals 27 medicines
Other names of the ATC group
- Czech: J05AF Nukleosidové a nukleotidové inhibitory reverzní transkriptázy
- French: J05AF inhibiteurs de la transcriptase reverse nucléosidiques et nucléotidiques
- German: J05AF Nukleosidale und nukleotidale Inhibitoren der Reversen Transkriptase
- German: J05AF Nukleosidale und nukleotidale Inhibitoren der Reversen Transkriptase
- Italian: J05AF Nucleosidi e nucleotidi inibitori della transcrittasi inversa
- Polish: J05AF Nukleozydowe i nukleotydowe inhibitory odwrotnej transkryptazy
- Turkish: J05AF Nükleozid ve nükleotid ters transkriptaz inhibitörleri
- Portuguese (Brazil): J05AF Nucleosídeos e nucleotídeos inibidores da transcriptase reversa
- Slovak: J05AF Nukleozidové a nukleotidové inhibítory reverznej transkriptázy
- German (Switzerland): J05AF Nukleosidale und nukleotidale Inhibitoren der Reversen Transkriptase
- French (Switzerland): J05AF Inhibiteurs de la transcriptase reverse nucléosidiques et nucléotidiques
- Italian (Switzerland): J05AF Nucleosidi e nucleotidi inibitori della transcrittasi inversa
- Dutch: J05AF Nucleoside en nucleotide reverse-transcriptaseremmers
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group J05AF
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.